Kidney Cancer News

Revised Guidelines Helping to Advance Kidney Cancer Care - OncLive



OncLive
 
Revised Guidelines Helping to Advance Kidney Cancer Care 
OncLive
Management of patients with localized kidney cancer became a more uniformed, guided, and evidence-based approach earlier this year with revised guidelines individually developed by the American Society of Clinical Oncology (ASCO), American ...

 


Combination of HDAC inhibitor with IL-2 promising - Nature.com



Combination of HDAC inhibitor with IL-2 promising 
Nature.com
Results of a single-arm phase I/II study show that addition of the class 1 HDAC inhibitor entinostat to high-dose IL-2 treatment in patients with metastatic clear cell renal cell carcinoma might be beneficial. In 47 patients at a median follow-up time ...

 


mTOR/TKI Combination Therapy in Kidney Cancer - OncLive



OncLive
 
mTOR/TKI Combination Therapy in Kidney Cancer 
OncLive
So, with the combination strategy of lenvatinib in the mTOR everolimus, one is targeting essentially 3 different pathways: their traditional VEGF pathway, which we know is associated with the VHL mutation, and it has strong rationale as a pathway for ...

 


Kidney Cancer: Continuing to Improve Survival - OncLive



OncLive
 
Kidney Cancer: Continuing to Improve Survival 
OncLive
James J. Hsieh, MD, PhD: Cancer is a very complicated disease, especially kidney cancer. So, everybody needs to be engaged and everybody needs to be involved before we can provide the best care for our patients. When a patient is presented with ...

 


Role of mTOR Inhibition in Kidney Cancer - OncLive



OncLive
 
Role of mTOR Inhibition in Kidney Cancer 
OncLive
James J. Hsieh, MD, PhD: mTOR inhibition has been at the forefront of kidney cancer treatment for the past 10 years. As I alluded to earlier, there are 2 different major mechanisms that are involved. One is VEGF inhibitors and one is mTOR inhibitors.

 


New study describes unique role of androgens in kidney cancer - News-Medical.net



New study describes unique role of androgens in kidney cancer 
News-Medical.net
A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the ...

and more » 


Exelixis Stock Rockets On Promising News In Kidney, Liver Cancers ... - Investor's Business Daily



Investor's Business Daily
 


Frontline TKI Strategies in Kidney Cancer - OncLive



OncLive
 
Frontline TKI Strategies in Kidney Cancer 
OncLive
Martin H. Voss, MD: We know that different molecular processes can drive cancerous growth in the kidneys, and we know that the cardinal event that we have therapeutically targeted in kidney cancer is the functional loss of VHL and the upregulation of ...

 


Kidney cancer breakthrough: THIS could be why more men than women suffer from symptoms - Express.co.uk



Express.co.uk
 
Kidney cancer breakthrough: THIS could be why more men than women suffer from symptoms 
Express.co.uk
While women have androgens in their bodies, men have much higher levels, and this could be the reason why they are more susceptible to certain types of kidney cancer. Researchers found that men were five times as likely to suffer from kidney cancer ...

 


Imaging and Screening of Kidney Cancer. - UroToday



Imaging and Screening of Kidney Cancer. 
UroToday
Renal cell carcinoma (RCC) exhibits a diverse and heterogeneous disease spectrum, but insight into its molecular biology has provided an improved understanding of potential risk factors, oncologic behavior, and imaging features. Computed tomography ...